These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14572139)

  • 1. Metabolic changes in the knockout mouse for Canavan's disease: implications for patients with Canavan's disease.
    Surendran S; Matalon KM; Szucs S; Tyring SK; Matalon R
    J Child Neurol; 2003 Sep; 18(9):611-5. PubMed ID: 14572139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of Canavan's disease: from human to mouse.
    Surendran S; Matalon KM; Tyring SK; Matalon R
    J Child Neurol; 2003 Sep; 18(9):604-10. PubMed ID: 14572138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease.
    Wittsack HJ; Kugel H; Roth B; Heindel W
    J Magn Reson Imaging; 1996; 6(6):889-93. PubMed ID: 8956134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case 15-1998: elevated N-acetylaspartic acid activity in Canavan's disease.
    Breslau J
    N Engl J Med; 1998 Aug; 339(9):636. PubMed ID: 9722443
    [No Abstract]   [Full Text] [Related]  

  • 5. Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene.
    Janson CG; Kolodny EH; Zeng BJ; Raghavan S; Pastores G; Torres P; Assadi M; McPhee S; Goldfarb O; Saslow B; Freese A; Wang DJ; Bilaniuk L; Shera D; Leone P
    Ann Neurol; 2006 Feb; 59(2):428-31. PubMed ID: 16437572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
    Aydinli N; Calişkan M; Calay M; Ozmen M
    Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Magnetic resonance tomography and localized proton spectroscopy in 2 siblings with Canavan's disease].
    Engelbrecht V; Rassek M; Gärtner J; Kahn T; Mödder U
    Rofo; 1995 Sep; 163(3):238-44. PubMed ID: 7548871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.
    Harris K; Lin A; Bhattacharya P; Tran T; Wong W; Ross B
    Adv Exp Med Biol; 2006; 576():263-73; discussion 361-3. PubMed ID: 16802718
    [No Abstract]   [Full Text] [Related]  

  • 9. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.
    Madhavarao CN; Arun P; Moffett JR; Szucs S; Surendran S; Matalon R; Garbern J; Hristova D; Johnson A; Jiang W; Namboodiri MA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5221-6. PubMed ID: 15784740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Features and Diagnosis of Canavan's Disease: A Case Series of Iranian Patients.
    Karimzadeh P; Jafari N; Nejad Biglari H; Rahimian E; Ahmadabadi F; Nemati H; Nasehi MM; Ghofrani M; Mollamohammadi M
    Iran J Child Neurol; 2014; 8(4):66-71. PubMed ID: 25657773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canavan disease: studies on the knockout mouse.
    Matalon R; Michals-Matalon K; Surendran S; Tyring SK
    Adv Exp Med Biol; 2006; 576():77-93; discussion 361-3. PubMed ID: 16802706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease.
    Baslow MH
    J Mol Neurosci; 2000 Oct; 15(2):61-9. PubMed ID: 11220786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental retardation and hypotonia seen in the knock out mouse for Canavan disease is not due to succinate semialdehyde dehydrogenase deficiency.
    Surendran S; Ezell EL; Quast MJ; Wei J; Tyring SK; Michals-Matalon K; Matalon R
    Neurosci Lett; 2004 Mar; 358(1):29-32. PubMed ID: 15016427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canavan disease: a monogenic trait with complex genomic interaction.
    Surendran S; Michals-Matalon K; Quast MJ; Tyring SK; Wei J; Ezell EL; Matalon R
    Mol Genet Metab; 2003; 80(1-2):74-80. PubMed ID: 14567959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan's disease.
    Velinov M; Zellers N; Styles J; Wisniewski K
    Clin Genet; 2008 Mar; 73(3):288-9. PubMed ID: 18070137
    [No Abstract]   [Full Text] [Related]  

  • 16. Dietary treatment proposed for Canavan's disease.
    Chen V
    Lancet Neurol; 2005 May; 4(5):273. PubMed ID: 15861552
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of glutamate transporter, GABRA6, serine proteinase inhibitor 2 and low levels of glutamate and GABA in the brain of knock-out mouse for Canavan disease.
    Surendran S; Rady PL; Michals-Matalon K; Quast MJ; Rassin DK; Campbell GA; Ezell EL; Wei J; Tyring SK; Szucs S; Matalon R
    Brain Res Bull; 2003 Aug; 61(4):427-35. PubMed ID: 12909286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild elevation of N-acetylaspartic acid and macrocephaly: diagnostic problem.
    Surendran S; Bamforth FJ; Chan A; Tyring SK; Goodman SI; Matalon R
    J Child Neurol; 2003 Nov; 18(11):809-12. PubMed ID: 14696913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of computed tomography, magnetic resonance imaging, and localized 1H magnetic resonance spectroscopy in Canavan's disease: a case report.
    Marks HG; Caro PA; Wang ZY; Detre JA; Bogdan AR; Gusnard DA; Zimmerman RA
    Ann Neurol; 1991 Jul; 30(1):106-10. PubMed ID: 1929222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational analysis of deleterious missense mutations in aspartoacylase that cause Canavan's disease.
    Sreevishnupriya K; Chandrasekaran P; Senthilkumar A; Sethumadhavan R; Shanthi V; Daisy P; Nisha J; Ramanathan K; Rajasekaran R
    Sci China Life Sci; 2012 Dec; 55(12):1109-19. PubMed ID: 23233226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.